Label Changes for:
Victoza (Liraglutide [rDNA origin]) Injection
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- Allergic reactions: rash and pruritus
Clinical Trials Experience
- Infomration added to section based on trial reports, Liraglutide Effect and Action in Diabetes (LEAD-6): Effect on glycemic control of liraglutide or exenatide added to metformin, sulphonylurea or a combination of both in subjects with type 2 diabetes.